AGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGL
NEW ORLEANS, April 10, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they: i) purchased or otherwise acquired the Company’s shares between April 15, 2021 and February 27, 2024, inclusive (the “Class Period”), and/or ii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s April 2021 initial public offering (“IPO”), and/or iii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s May 2023 secondary public offering (“SPO”). These actions are pending in the United States District Courts for the Western District of Texas and Southern District of New York.
Get Help
Agilon health investors should visit us at https://www.claimsfiler.com/cases/nyse-agl or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuits
Agilon and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifically, lowering its 2023 Medical Margin expectation to “$340 million to $360 million, approximately $110 million below the previous guidance range…due to $90 million in higher-than-expected medical costs” and that its Chief Financial Officer, Timothy Bensley would retire and be replaced later in the year.
On this news, the price of agilon’s shares fell $3.45, or 28.6%, to close at $8.63 on January 5, 2024.
The first-filed case is New England Teamsters Pension Fund v. agilon health, inc., 24-cv-00297. A second case, Hope v. agilon health, inc., 24-cv-00305, extended the Class Period. A third case, Indiana Public Retirement System v. agilon health, inc., 24-cv- 2506, extended the Class Period and Class Definition.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing